These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3145286)

  • 1. Effects of sodium valproate and oxygen on the CD-1 mouse fetus.
    Paulson RB; Sucheston ME; Hayes TG; Weiss HS; Sachs LA; Oca M; Kernan B; Weiss S
    J Craniofac Genet Dev Biol; 1988; 8(1):35-45. PubMed ID: 3145286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sodium valproate and oxygen on the craniofacial skeletal pattern in the CD-1 mouse embryo.
    Paulson RB; Sucheston ME; Hayes TG; Weiss HS
    J Craniofac Genet Dev Biol; 1989; 9(4):339-48. PubMed ID: 2517505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The developmental toxicity of inhaled methanol in the CD-1 mouse, with quantitative dose-response modeling for estimation of benchmark doses.
    Rogers JM; Mole ML; Chernoff N; Barbee BD; Turner CI; Logsdon TR; Kavlock RJ
    Teratology; 1993 Mar; 47(3):175-88. PubMed ID: 8475461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium valproate-induced cardiovascular abnormalities in the Jcl:ICR mouse fetus: peak sensitivity of gestational day and dose-dependent effect.
    Sonoda T; Ohdo S; Ohba K; Okishima T; Hayakawa K
    Teratology; 1993 Aug; 48(2):127-32. PubMed ID: 8211818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogenic effects of dosage levels and time of administration of carbamazepine, sodium valproate, and diphenylhydantoin on craniofacial development in the CD-1 mouse fetus.
    Eluma FO; Sucheston ME; Hayes TG; Paulson RB
    J Craniofac Genet Dev Biol; 1984; 4(3):191-210. PubMed ID: 6438150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of smokeless tobacco on the development of the CD-1 mouse fetus.
    Paulson R; Shanfeld J; Sachs L; Ismail M; Paulson J
    Teratog Carcinog Mutagen; 1988; 8(2):81-93. PubMed ID: 2899919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratogenicity and developmental toxicity of valproic acid in rats.
    Vorhees CV
    Teratology; 1987 Apr; 35(2):195-202. PubMed ID: 3110992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constant rate exposure of pregnant hamsters to arsenate during early gestation.
    Ferm VH; Hanlon DP
    Environ Res; 1985 Aug; 37(2):425-32. PubMed ID: 4017994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of heart malformations in B6C3F1 mouse fetuses induced by in utero exposure to methyl chloride.
    Wolkowski-Tyl R; Lawton AD; Phelps M; Hamm TE
    Teratology; 1983 Apr; 27(2):197-206. PubMed ID: 6867941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teratogenesis of calcium valproate in rats.
    Ong LL; Schardein JL; Petrere JA; Sakowski R; Jordan H; Humphrey RR; Fitzgerald JE; de la Iglesia FA
    Fundam Appl Toxicol; 1983; 3(2):121-6. PubMed ID: 6409702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratogenic effects of sodium valproate in the Jcl: ICR mouse fetus.
    Sonoda T; Ohdo S; Ohba K; Okishima T; Hayakawa K
    Acta Paediatr Jpn; 1990 Oct; 32(5):502-7. PubMed ID: 2284927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental toxicity study with triethylene glycol given by gavage to CD rats and CD-1 mice.
    Ballantyne B; Snellings WM
    J Appl Toxicol; 2005; 25(5):418-26. PubMed ID: 16092104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.
    Hrubec TC; Yan M; Ye K; Salafia CM; Holladay SD
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Dec; 288(12):1303-9. PubMed ID: 17075842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse.
    Nau H
    Toxicol Appl Pharmacol; 1985 Sep; 80(2):243-50. PubMed ID: 3927520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between ossification and body weight of the CD-1 mouse fetus exposed in utero to anticonvulsant drugs.
    Sucheston ME; Hayes TG; Eluma FO
    Teratog Carcinog Mutagen; 1986; 6(6):537-46. PubMed ID: 2881368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratogenic effects of valproate in the CD-1 mouse fetus.
    Paulson RB; Sucheston ME; Hayes TG; Paulson GW
    Arch Neurol; 1985 Oct; 42(10):980-3. PubMed ID: 3929751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid developmental toxicity and pharmacokinetics in the rhesus monkey: an interspecies comparison.
    Hendrickx AG; Nau H; Binkerd P; Rowland JM; Rowland JR; Cukierski MJ; Cukierski MA
    Teratology; 1988 Oct; 38(4):329-45. PubMed ID: 3149039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratogenic and postnatal developmental studies of morphine in Sprague-Dawley rats.
    Fujinaga M; Mazze RI
    Teratology; 1988 Nov; 38(5):401-10. PubMed ID: 3238597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.